Recent evidence strongly suggested that CRL3 exerts pivotal roles in the regulation of disease conditions, including cancer progression.[4] Moreover, CRL3 recruits specific substrates through the binding of Cullins to their substrate-binding adaptors. The gene discussed is IL31RA; the disease is cancer.